pharma_menu
OMICS Group’s
International Conference and Exhibition on Pharmaceutical Regulatory Affairs
Theme: Research & Advancements in Pharmaceutical Regulatory Affairs
Dates: 6-7 September 2011
Venue: BWI Airport Marriott, Baltimore, Maryland, USA
Tel : Fax : Toll Free :
+1-650-268-9744 +1-650-618-1414 +91-040-40131662
Website:
https://www.omicsonline.org/pharma2011/
Submit Your Abstract Online at:
https://www.omicsonline.org/pharma2011/abstract.php
(OR) e-mail to: pharma2011@omicsonline.org
We warmly invite you to attend and submit your abstract to the most important The International Conference and Exhibition on Pharmaceutical Regulatory Affairs .
Pharma-2011 is comprised of 7 tracks and 28 sessions designed to offer comprehensive sessions that address current issues in Pharmaceutical Regulatory Affairs. Please submit your abstract to any of the following track.
Track 1: Regulatory Affairs for Drugs
Track 1.1: Regulatory Aspects of Biotechnological Products
Track 1.2: Quality Assurance/Quality Risk Management
Track 1.3: Clinical Trials in Emerging Markets
Track 1.4: Drug Regulatory Affairs
Track 2: Biologics and Medical Devices
Track 2.1: Clinical Trial Design for Medical Devices
Track 2.2: Biologics & Design Control
Track 2.3: Process Validation for Drugs and Biologics
Track 2.4: Bioengineered Pharmaceutical Products
Track 3: Drug Designing & Development
Track 3.1: Drug Metabolism in Drug Discovery and Development
Track 3.2: Analytical Method Validations
Track 3.3: Epidemiology of Drug-Drug Interactions
Track 3.4: Biochemical Mechanisms of Drug Toxicity
Track 4: Safety and Quality Regulation
Track 4.1: Safety and efficacy of prescription drugs
Track 4.2: Training Needs in Regulatory Science for the Biopharmaceutical Industry
Track 4.3: Drug Labelling Regulations
Track 4.4: Good regulatory practices
Track 5: Regulatory Affairs: Compliances
Track 5.1: Regulatory Environment: Clinical Trials
Track 5.2: Quality System Frame Work for Pharmaceutical Products
Track 5.3: Regulatory Aspects of NDA and ANDA: Regulatory Filing and Submissions
Track 5.4: Development and Updates of the Pharmaceutical Regulatory Systems
Track 6: Product Manufacturing Procedures
Track 6.1: Good manufacturing pratices
Track 6.2: Environmental Aspects
Track 6.3: Types of Production activities
Track 6.4: Methods to Enhance Product Quality
Track-7: Advances in Gene therapy
Track 7-1 : Human Gene Therapy (Human Genome Project)
Track 7-2 : Viral vectors and Gene Therapy
Track 7-3 : Genetic Screening & DNA Testing
Track 7-4 : Development in Cell Cloning
Participants list Academic
Untitled Document
Tulane University, USA
Stanford University, USA
Texas A&M Health Science Center, USA
University of Washington,USA
University of Illinois, USA
Van Andel Research Institute, USA
Fourth Military Medical University, China
Ohio State University, USA
University at Albany, USA
Harvard Medical School, USA
University of Pittsburgh, USA
Northeastern University, USA
Thomas Jefferson University, USA
Albert Einstein College of Medicine, USA
UAE University, UAE
Nankai University School of Medicine, China
University of Milan, Italy
Medicine Kuwait University, Kuwait
Swiss Institute of Bioinformatics, Switzerland
University of Pittsburgh, USA
National Cancer Institute, USA
Wake Forest University, China
Navy General Hospital, China
University of Texas, USA
St.Petersburg State University, Russia
Seoul National University, South Korea
University of Wisconsin-Madison,USA
Ecole Polytechnique, Canada
Boys Town National Research Hospital, USA
University of Pittsburgh, USA
Academy of Sciences of the Czech Republic, Czech Republic
New Jersey Institute of Technology, USA
International Stem Cell Corporation, USA
University of Minho, Portugal
Virginia University, USA
UMDNJ-Robert Wood Johnson Medical School, USA
Keio university, Japan
Sanford Burnham Medical Research Institute, USA
State University of New York Downstate Medical Center, USA
Cornell University, USA
Radboud University Nijmegen Medical Centre, Netherlands
Participants list Business
Untitled Document
Cadila Pharmaceuticals, India
Chemical Works of Gedeon Richter, Hungary
3S-Pharmacological Consultation & Research GmbH, Germany
Royal Brisbane and Women’s Hospital, Australia
Psoriasis and Cutaneous Inflammation Research Laboratory, USA
Alcon Laboratories Inc., USA
National Institute for Materials Science (NIMS), Japan
Grup de Recerca de Reumatologia (IRHVH), Spain
Bayer Health Care, Richmond, USA
Crown Bioscience Inc., China
Hammersmith Hospital, London
Van Drie Research LLC, USA
Dr.Reddy’s labs, India
Merck Research Laboratories, USA
National Institute of Pharmaceutical Education and Research (NIPER), India
AstraZeneca R&D Boston, USA
Abbott Laboratories, USA
Hutchison MediPharma Limited, China
Sage Bionetworks, USA
Central Drug Research Institute, India
Glenmark Pharmaceuticals, India
National Institute for Interdisciplinary Science & Technology (NIIST) , India
Novartis Campus, Austria